Applied Biological Laboratories, maker of Biovanta, to present at American Society of Microbiology’s Clinical Virology Symposium 2024
Researchers will showcase results of a randomized clinical trial demonstrating Biovanta's efficacy in reducing common cold symptoms by strengthening the respiratory barrier and controlling inflammation. The presentation will also include preclinical data on antiviral formulas targeting rhinovirus and influenza.